Transdiagnostic Behavior Therapy Vs TAU for Adjustment Disorder Following Traumatic Event Exposure
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · May 22, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a type of therapy called Transdiagnostic Behavior Therapy (TBT) to see if it can help reduce symptoms of Adjustment Disorder (AjD) in military service members and veterans. Adjustment Disorder is a mental health condition that can happen after experiencing a very stressful event, such as losing a comrade or being involved in a serious accident. The researchers want to find out if TBT is more effective than the usual treatment, which is a problem-solving therapy called Moving Forward Problem Solving Therapy.
To join the study, participants need to be at least 18 years old and have served in the military. They must also have a diagnosis of Adjustment Disorder and have been stable on any medications for at least four weeks. The study is looking for adults of any gender. During the trial, participants will receive either TBT or the usual treatment and will be monitored for their symptoms. This research aims to provide better treatment options for those struggling with AjD, which is often not adequately addressed.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult male or female over the age of 18 that has served, or is currently serving, in the military.
- • Stable psychotropic medication for at least 4 weeks if applicable
- • Current DSM-5 diagnosis of Adjustment Disorder
- Exclusion Criteria:
- • Active psychosis
- • Suicidal ideation with clear intent
- • Severe substance use
About The University Of Texas Health Science Center, Houston
The University of Texas Health Science Center at Houston (UTHealth) is a leading academic institution dedicated to advancing health through education, research, and clinical practice. As a prominent sponsor of clinical trials, UTHealth leverages its extensive resources and expertise in biomedical research to facilitate innovative studies aimed at improving patient outcomes. The institution is committed to fostering a collaborative environment that promotes scientific discovery and the translation of research findings into effective healthcare solutions, all while adhering to the highest ethical standards and regulatory guidelines. With a multidisciplinary approach, UTHealth plays a critical role in addressing complex health challenges and enhancing the quality of life in diverse communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Patients applied
Trial Officials
Ron Acierno, PhD
Principal Investigator
McGovern Medical School at UTHealth Houston
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported